Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Biologic therapy. Chemotherapy. Albany Medical Center, Albany, N.Y. , United States

Survival: 11.3 months
Toxicity Grade: 5
Treatments: Biologic therapy
Drugs: Taxotere
Country: United States
City/State/Province: Albany, N.Y.
Hospital: Albany Medical Center
Journal: Link
Date: 5/2005

Patients: This Phase II study involved 39 patients with metastatic or recurrent non-small-cell lung cancer (26 with adenocarcinoma). Twenty-six patients were men, and thirteen were women. The average age was 60.5 years. All patients had received one platinum-based chemotherapy treatment before this study.

Treatment: The treatment consisted of one chemotherapeutic agent, docetaxel and one COX-2 inhibitor, celecoxib.

Toxicity: One patient died of neutropenic sepsis while on therapy. Grade 3-4 toxicities included neutropenia, dyspnea, fatigue, hyponatremia, hypoxia, and neuropathy.

Results: The median overall survival was 11.3 months.

Support: Aventis Pharmaceuticals provided financial support for this study. Aventis manufactures and markets docetaxel.

Correspondence: Antonius A. Miller, MD

E-mail to a Friend Email Physician More Information